Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01092312 · ClinicalTrials.gov registry record · NA
Signature Personalised Patient Care System With the Vanguard Knee System Study
A NA study, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- NA
- Development phase
- 325
- Enrollment target
NCT01092312 is a NA study that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 325 participants.
The verdict
NCT01092312, a NA study, was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- NA
- Development phase
- 325 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the percentage cases which have ideal mechanical axial alignment using the Vanguard total Knee implant with the Signature cutting blocks is higher than those without the use of Signature when measured immediately post-operatively.
Interventions
- PROCEDURE Vanguard Knee System with Signature Knee Guide
- PROCEDURE Vanguard Knee System with conventional Instruments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 325 participants |
| Start Date | 2010-03 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01092312
The ClinicalTrials.gov registry entry for NCT01092312 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 325 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vanguard Knee System with Signature Knee Guide is the first listed.
NCT01092312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01092312 about?
NCT01092312 is a clinical study titled "Signature Personalised Patient Care System With the Vanguard Knee System Study". The purpose of this study is to determine whether the percentage cases which have ideal mechanical axial alignment using the Vanguard total Knee implant with the Signature cutting blocks is higher than those without the use of Signature when measured immediately post-operatively.
What is the current status of trial NCT01092312?
This trial is currently terminated. It is a NA study. The enrollment target is 325 participants. The study started on 2010-03. Estimated completion is 2016-09.
What interventions are being tested in trial NCT01092312?
The interventions under investigation include: Vanguard Knee System with Signature Knee Guide (PROCEDURE), Vanguard Knee System with conventional Instruments (PROCEDURE).
Who is sponsoring clinical trial NCT01092312?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.